Drug Shortage Report for PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Report ID | 173923 |
Drug Identification Number | 02504545 |
Brand name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP |
Common or Proper name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 VIALS 5 ML |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-08-31 |
Estimated end date | 2022-12-02 |
Actual end date | 2022-12-12 |
Shortage status | Resolved |
Updated date | 2022-12-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-13 | English | Compare |
v4 | 2022-12-12 | French | Compare |
v3 | 2022-12-12 | English | Compare |
v2 | 2022-11-07 | French | Compare |
v1 | 2022-11-07 | English | Compare |
Showing 1 to 5 of 5